Susquehanna Fundamental Investments’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-154,045
| Closed | -$1.29M | – | 728 |
|
|
2025
Q1 | $1.29M | Buy |
+154,045
| New | +$1.29M | 0.02% | 634 |
|
|
2023
Q3 | – | Sell |
-17,064
| Closed | -$52.9K | – | 371 |
|
|
2023
Q2 | $52.9K | Sell |
17,064
-42,400
| -71% | -$131K | ﹤0.01% | 620 |
|
|
2023
Q1 | $82.7K | Sell |
59,464
-8,060
| -12% | -$11.2K | ﹤0.01% | 909 |
|
|
2022
Q4 | $134K | Sell |
67,524
-106,084
| -61% | -$211K | ﹤0.01% | 1103 |
|
|
2022
Q3 | $351K | Buy |
+173,608
| New | +$351K | 0.01% | 1114 |
|
|
2022
Q1 | – | Sell |
-42,100
| Closed | -$202K | – | 1528 |
|
|
2021
Q4 | $202K | Sell |
42,100
-54,519
| -56% | -$262K | 0.01% | 1247 |
|
|
2021
Q3 | $516K | Buy |
96,619
+15,649
| +19% | +$83.6K | 0.01% | 1189 |
|
|
2021
Q2 | $415K | Sell |
80,970
-23,205
| -22% | -$119K | 0.01% | 1236 |
|
|
2021
Q1 | $701K | Buy |
+104,175
| New | +$701K | 0.01% | 1021 |
|
|
2020
Q4 | – | Sell |
-119,600
| Closed | -$464K | – | 1485 |
|
|
2020
Q3 | $464K | Buy |
119,600
+15,500
| +15% | +$60.1K | 0.01% | 901 |
|
|
2020
Q2 | $496K | Buy |
+104,100
| New | +$496K | 0.02% | 618 |
|